On the recordOctober 16, 2017
There wasn't any investment in R and D that would justify that kind of increase.
Source
congress.govThere wasn't any investment in R and D that would justify that kind of increase.
Senator Collins criticizes pharmaceutical companies for unjustified price increases without R&D investment.
Share & report
More from Susan Collins
I'm still looking at it because it kept changing up until literally the very minute it passed.
Regardless of our views on the Fiscal Responsibility Act and accompanying implementation agreement, it is incumbent on all of us to follow the law as written—not as we would like it to be.